Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS
Clinical trial NCT02018926 · COMPLETED
Trial details
- NCT number
- NCT02018926
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.